These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 7690177)

  • 1. [Evaluation of prazosin in the treatment of benign hypertrophy of the prostate. A case-control study].
    Adriazola Semino M; García Cobo E; De la Calle Muñoz I; Tejeda Bañez E; Romero F
    Actas Urol Esp; 1993 Jul; 17(7):402-4. PubMed ID: 7690177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Therapeutic effectiveness and safety of prazosin in the symptomatic treatment of benign prostatic hypertrophy].
    Jiménez Cruz JF; Server Pastor G; Rioja Sanz C; Salinas Casado J; Vela Navarrete R; Virseda Chamorro M
    Actas Urol Esp; 1990; 14(1):31-5. PubMed ID: 1692659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alpha blocker prazosin for the treatment of benign prostatic hypertrophy (BPH).
    Punekar SV; Kelkar AR; Gavande PM; Rao NR; Date JA; Prem AR
    J Postgrad Med; 1995; 41(4):99-101. PubMed ID: 10707729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of prazosin on patients with symptoms of benign prostatic hypertrophy.
    Steven ID; Coffey GA; Graham NM; Wlodarczyk J; Curtis P
    Aust Fam Physician; 1993 Jul; 22(7):1260-4. PubMed ID: 7690542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical effects of distigmine bromide (Ubretid), a cholinesterase inhibitor, on micturition disturbance by benign prostatic hypertrophy--comparative study of distigmine bromide and the combination of distigmine bromide and adrenergic blocker].
    Katsumi T; Murayama K
    Hinyokika Kiyo; 1992 Sep; 38(9):1089-92. PubMed ID: 1384297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of branded versus generic terazosin hydrochloride in adults with benign prostatic hyperplasia: a randomized, open-label, crossover study in Taiwan.
    Tsai YS; Lan SK; Ou JH; Tzai TS
    Clin Ther; 2007 Apr; 29(4):670-82. PubMed ID: 17617290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of obstruction caused by prostatic hypertrophy with prazosin. 1-year follow-up].
    Server G; Ruiz JL; Vidal J; Gallego J; Osca JM; Jiménez Cruz JF
    Arch Esp Urol; 1991 Nov; 44(9):1037-40. PubMed ID: 1725478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Evaluation of the effectiveness of prazosin in conservative treatment of benign prostatic hypertrophy].
    Górecki R; Krzeski T; Wasik J; Borówka A
    Pol Tyg Lek; 1992 Jun 15-29; 47(24-26):549-51. PubMed ID: 1282713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alpha 1-adrenoceptor antagonists terazosin and doxazosin induce prostate apoptosis without affecting cell proliferation in patients with benign prostatic hyperplasia.
    Chon JK; Borkowski A; Partin AW; Isaacs JT; Jacobs SC; Kyprianou N
    J Urol; 1999 Jun; 161(6):2002-8. PubMed ID: 10332490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of prazosin on human prostatic adenoma tissue].
    Kaminka ME; Zhirnikova ML; Vinarov AZ; Mashkovskiĭ MD; Pytel' IuA
    Biull Eksp Biol Med; 1988 Aug; 106(8):187-8. PubMed ID: 2458142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of four different alpha1-blockers in benign prostatic hyperplasia patients with and without diabetes.
    Bozlu M; Ulusoy E; Cayan S; Akbay E; Görür S; Akbay E
    Scand J Urol Nephrol; 2004; 38(5):391-5. PubMed ID: 15764250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Symptomatic treatment of benign hypertrophy of the prostate. Comparative study of prazosin and serenoa repens].
    Adriazola Semino M; Lozano Ortega JL; García Cobo E; Tejeda Báñez E; Romero Rodríguez F
    Arch Esp Urol; 1992 Apr; 45(3):211-3. PubMed ID: 1384438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What is the best medical treatment for benign prostate hyperplasia?
    Evans MF; Frank J
    Can Fam Physician; 1997 Jun; 43():1073-4. PubMed ID: 9189295
    [No Abstract]   [Full Text] [Related]  

  • 14. Efficacy of terazosin and finasteride in symptomatic benign prostatic hyperplasia: A comparative study.
    Anwarul Islam AK; Kashem MA; Shameem IA; Kibria SA
    Bangladesh Med Res Counc Bull; 2005 Aug; 31(2):54-61. PubMed ID: 16967810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term study to assess the efficacy of tamsulosin in the control of symptoms and complications developed in patients with symptomatic benign prostatic hyperplasia (OMNICONTROL study): first-year follow-up report.
    Palacio A; Hernández C; Marqués A; Prats J; Espinosa FJ
    Arch Esp Urol; 2004 May; 57(4):451-60. PubMed ID: 15270291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prazosin: an evaluation of its clinical efficacy and safety in the treatment of benign prostatic hypertrophy.
    Urol Int; 1990; 45 Suppl 1():1-62. PubMed ID: 1690475
    [No Abstract]   [Full Text] [Related]  

  • 17. A multicenter, randomized, double-blind, placebo-controlled study to evaluate the safety and efficacy of terazosin in the treatment of benign prostatic hyperplasia.
    Elhilali MM; Ramsey EW; Barkin J; Casey RW; Boake RC; Beland G; Fradet Y; Trachtenberg J; Orovan WL; Schick E; Klotz LH
    Urology; 1996 Mar; 47(3):335-42. PubMed ID: 8633398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The mechanism of action of the alpha-adrenoblocker prazosin on bladder function in patients with benign prostatic hyperplasia].
    Loran OB; Vishnevskiĭ AE
    Urol Nefrol (Mosk); 1997; (4):19-22. PubMed ID: 9381614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of combined therapy with terazosin and tolteradine for patients with lower urinary tract symptoms associated with benign prostatic hyperplasia: a prospective study.
    Yang Y; Zhao XF; Li HZ; Wang W; Zhang Y; Xiao H; Zhang X
    Chin Med J (Engl); 2007 Mar; 120(5):370-4. PubMed ID: 17376305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective randomized comparison of high energy transurethral microwave thermotherapy versus alpha-blocker treatment of patients with benign prostatic hyperplasia.
    Djavan B; Roehrborn CG; Shariat S; Ghawidel K; Marberger M
    J Urol; 1999 Jan; 161(1):139-43. PubMed ID: 10037386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.